An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery

Rampino, 2013, Chitosan nanoparticles: Preparation, size evolution and stability, Int. J. Pharm., 455, 219, 10.1016/j.ijpharm.2013.07.034

Nagpal, 2010, Chitosan Nanoparticles: A Promising System in Novel Drug Delivery, Chem. Pharm. Bull., 58, 1423, 10.1248/cpb.58.1423

Sorlier, 2001, Relation between the Degree of Acetylation and the Electrostatic Properties of Chitin and Chitosan, Biomacromolecules, 2, 765, 10.1021/bm015531+

1994, Water-solubility of partially N-acetylated chitosans as a function of pH: Effect of chemical composition and depolymerisation, Carbohydr. Polym., 25, 65, 10.1016/0144-8617(94)90140-6

Knoop, 2015, Chitosan films and blends for packaging material, Carbohydr. Polym., 116, 237, 10.1016/j.carbpol.2014.07.039

Chen, 2013, Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules, Adv. Drug Deliv. Rev., 65, 865, 10.1016/j.addr.2012.10.010

Shukla, 2013, Chitosan-based nanomaterials: A state-of-the-art review, Int. J. Biol. Macromol., 59, 46, 10.1016/j.ijbiomac.2013.04.043

Strobl, G.R. (2007). The Physics of Polymers, Springer.

Park, 2001, Physical properties of PVOH/chitosan-blended films cast from different solvents, Food Hydrocoll., 15, 499, 10.1016/S0268-005X(01)00055-8

Mima, 1983, Highly deacetylated chitosan and its properties, J. Appl. Polym. Sci., 28, 1909, 10.1002/app.1983.070280607

Risbud, 2000, pH-sensitive freeze-dried chitosan–polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery, J. Control. Release, 68, 23, 10.1016/S0168-3659(00)00208-X

Kolhe, 2003, Improvement in Ductility of Chitosan through Blending and Copolymerization with PEG: FTIR Investigation of Molecular Interactions, Biomacromolecules, 4, 173, 10.1021/bm025689+

Koul, 2011, Interpenetrating polymer network (IPN) nanogels based on gelatin and poly(acrylic acid) by inverse miniemulsion technique: Synthesis and characterization, Colloids Surf. B Biointerfaces, 83, 204, 10.1016/j.colsurfb.2010.11.007

Yahaya, 2010, Rheological study of chitosan and its blends: An overview, Maejo Int. J. Sci. Technol., 4, 210

Dambies, 2001, Preparation of Chitosan Gel Beads by Ionotropic Molybdate Gelation, Biomacromolecules, 2, 1198, 10.1021/bm010083r

Grenha, 2012, Microencapsulated chitosan nanoparticles for pulmonary protein delivery: In vivo evaluation of insulin-loaded formulations, J. Control. Release, 157, 383, 10.1016/j.jconrel.2011.08.008

Thanou, 2000, Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers, J. Control. Release, 64, 15, 10.1016/S0168-3659(99)00131-5

Hornof, 2003, Thiolated polymers—Thiomers: Synthesis and in vitro evaluation of chitosan–2-iminothiolane conjugates, Int. J. Pharm., 260, 229, 10.1016/S0378-5173(03)00271-0

Sadeghi, 2008, Permeation enhancer effect of chitosan and chitosan derivatives: Comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells, Eur. J. Pharm. Biopharm., 70, 270, 10.1016/j.ejpb.2008.03.004

Yin, 2009, Biomaterials Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery, Biomaterials, 30, 5691, 10.1016/j.biomaterials.2009.06.055

Cui, 2009, Preparation, Characterization and Oral Delivery of Insulin Loaded Carboxylated Chitosan Grafted Poly (methyl methacrylate) Nanoparticles, Biomacromolecules, 10, 1253, 10.1021/bm900035u

Kurita, 1996, Preparation of Chitin/Polystyrene Hybrid Materials by Efficient Graft Copolymerization Based on Mercaptochitin, Macromolecules, 29, 1939, 10.1021/ma951184i

Furlani, 2017, Highly monodisperse colloidal coacervates based on a bioactive lactose-modified chitosan: From synthesis to characterization, Carbohydr. Polym., 174, 360, 10.1016/j.carbpol.2017.06.097

Sacco, 2016, Donati Insight into the ionotropic gelation of chitosan using tripolyphosphate and pyrophosphate as cross-linkers, Int. J. Biol. Macromol., 92, 476, 10.1016/j.ijbiomac.2016.07.056

Liu, S., Yang, S., and Ho, P.C. (2017). Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain. Asian J. Pharm. Sci.

Singh, 2009, Nanoparticle-based targeted drug delivery, Exp. Mol. Pathol., 86, 215, 10.1016/j.yexmp.2008.12.004

Yuan, 2013, Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release, Int. J. Pharm., 446, 191, 10.1016/j.ijpharm.2013.02.024

Miladi, 2015, Enhancement of alendronate encapsulation in chitosan nanoparticles, J. Drug Deliv. Sci. Technol., 30, 391, 10.1016/j.jddst.2015.04.007

Siafaka, 2015, Chitosan derivatives as effective nanocarriers for ocular release of timolol drug, Int. J. Pharm., 495, 249, 10.1016/j.ijpharm.2015.08.100

Siepmann, 2012, Modeling of diffusion controlled drug delivery, J. Control. Release, 161, 351, 10.1016/j.jconrel.2011.10.006

Chorilli, 2017, An overview of carboxymethyl derivatives of chitosan: Their use as biomaterials and drug delivery systems, Mater. Sci. Eng. C, 77, 1349, 10.1016/j.msec.2017.03.198

1996, Mechanisms of polymer degradation and erosion, Biomaterials, 17, 103, 10.1016/0142-9612(96)85755-3

Pawar, 2013, Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: Effect of mucoadhesive coating on antigen uptake and immune adjuvant activity, Eur. J. Pharm. Biopharm., 85, 550, 10.1016/j.ejpb.2013.06.017

Manca, 2008, Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles, Colloids Surf. B Biointerfaces, 67, 166, 10.1016/j.colsurfb.2008.08.010

Wang, 2013, Preparation, characterization and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4, Int. J. Nanomed., 8, 1141

Bowman, 2006, Chitosan Nanoparticles for Oral Drug and Gene Delivery, Int. J. Nanomed., 1, 117, 10.2147/nano.2006.1.2.117

Wang, 2011, Recent advances of chitosan nanoparticles as drug carriers, Int. J. Nanomed., 6, 765

Palacio, 2016, PEGylation of PLA nanoparticles to improve mucus-penetration and colloidal stability for oral delivery systems, Curr. Opin. Chem. Eng., 11, 14, 10.1016/j.coche.2015.11.006

Dube, 2010, Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallate, Eur. J. Pharm. Sci., 41, 219, 10.1016/j.ejps.2010.06.010

Barbieri, 2015, Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles, Int. J. Pharm., 491, 99, 10.1016/j.ijpharm.2015.06.021

Feng, 2013, Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: In vitro and in vivo evaluation, Int. J. Pharm., 457, 158, 10.1016/j.ijpharm.2013.07.079

John, 2016, Sunitinib loaded chitosan nanoparticles formulation and its evaluation, Int. J. Biol. Macromol., 82, 952, 10.1016/j.ijbiomac.2015.10.079

Diop, 2015, Design, characterisation and bioefficiency of insulin-chitosan nanoparticles after stabilisation by freeze-drying or cross-linking, Int. J. Pharm., 491, 402, 10.1016/j.ijpharm.2015.05.065

Xue, 2015, Development of chitosan nanoparticles as drug delivery system for a prototype capsid inhibitor, Int. J. Pharm., 495, 771, 10.1016/j.ijpharm.2015.08.056

2002, Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A, Int. J. Pharm., 249, 101, 10.1016/S0378-5173(02)00461-1

Gao, 2016, Chitosan based nanoparticles as protein carriers for efficient oral antigen delivery, Int. J. Biol. Macromol., 91, 716, 10.1016/j.ijbiomac.2016.06.015

Bagre, 2013, Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: In vitro and in vivo assessment, Int. J. Pharm., 456, 31, 10.1016/j.ijpharm.2013.08.037

Wang, J., Tan, J., Luo, J., Huang, P., Zhou, W., Chen, L., Long, L., Zhang, L., Zhu, B., and Yang, L. (2017). Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy. J. Nanobiotechnol., 15.

Huang, 2014, Preparing, characterizing and evaluating chitosan/fucoidan nanoparticles as oral delivery carriers, J. Polym. Res., 21, 415, 10.1007/s10965-014-0415-6

Shi, 2018, Surface-modified PLGA nanoparticles with chitosan for oral delivery of tolbutamide, Colloids Surf. B Biointerfaces, 161, 67, 10.1016/j.colsurfb.2017.10.037

Derakhshandeh, 2012, Role of chitosan nanoparticles in the oral absorption of Gemcitabine, Int. J. Pharm., 437, 172, 10.1016/j.ijpharm.2012.08.008

Maity, 2017, Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals—An in vitro and in vivo approach, Carbohydr. Polym., 170, 124, 10.1016/j.carbpol.2017.04.066

Liang, 2016, Synthesis and controlled-release properties of chitosan/β-Lactoglobulin nanoparticles as carriers for oral administration of epigallocatechin gallate, Food Sci. Biotechnol., 25, 1583, 10.1007/s10068-016-0244-y

Aluani, 2017, Evaluation of biocompatibility and antioxidant efficiency of chitosan-alginate nanoparticles loaded with quercetin, Int. J. Biol. Macromol., 103, 771, 10.1016/j.ijbiomac.2017.05.062

Verhoef, 2001, Chitosan for mucosal vaccination, Adv. Drug Deliv. Rev., 52, 139, 10.1016/S0169-409X(01)00197-1

Casettari, 2014, Chitosan in nasal delivery systems for therapeutic drugs, J. Control. Release, 190, 189, 10.1016/j.jconrel.2014.05.003

Lisbeth, 2003, Nasal drug delivery—Possibilities, problems and solutions, J. Control. Release, 87, 187, 10.1016/S0168-3659(02)00363-2

Shahnaz, 2012, Thiolated chitosan nanoparticles for the nasal administration of leuprolide: Bioavailability and pharmacokinetic characterization, Int. J. Pharm., 428, 164, 10.1016/j.ijpharm.2012.02.044

Ruge, 2013, Pulmonary drug delivery: From generating aerosols to overcoming biological barriers—Therapeutic possibilities and technological challenges, Lancet Respir. Med., 1, 402, 10.1016/S2213-2600(13)70072-9

Lytting, 2008, Biodegradable polymeric nanocarriers for pulmonary drug delivery Biodegradable polymeric nanocarriers for pulmonary drug delivery, Expert Opin. Drug Deliv., 56, 629, 10.1517/17425247.5.6.629

Islam, N., and Ferro, V. (2016). Recent Advances in Chitosan-Based Nanoparticulate Pulmonary Drug Delivery. Nanoscale, 14341–14358.

Rawal, 2017, Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis, Colloids Surf. B Biointerfaces, 154, 321, 10.1016/j.colsurfb.2017.03.044

Jafarinejad, 2012, Development of chitosan-based nanoparticles for pulmonary delivery of itraconazole as dry powder formulation, Powder Technol., 222, 65, 10.1016/j.powtec.2012.01.045

Ni, 2017, GABA B receptor ligand-directed trimethyl chitosan/tripolyphosphate nanoparticles and their pMDI formulation for survivin siRNA pulmonary delivery, Carbohydr. Polym., 179, 135, 10.1016/j.carbpol.2017.09.075

Trapani, 2013, Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticles, Int. J. Pharm., 447, 115, 10.1016/j.ijpharm.2013.02.035

Lee, D.-W., Shirley, S.A., Lockey, R.F., and Mohapatra, S.S. (2006). Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir. Res., 7.

Wang, 2008, Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting, Eur. J. Pharm. Biopharm., 70, 735, 10.1016/j.ejpb.2008.07.005

Janes, 2004, Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice, Eur. J. Pharm. Biopharm., 57, 123, 10.1016/j.ejpb.2003.09.006

Verhoef, 2001, Chitosan and its derivatives in mucosal drug and vaccine delivery, Eur. J. Pharm. Sci., 14, 201, 10.1016/S0928-0987(01)00172-5

Marguerite, 2006, Chitin and chitosan: Properties and applications, Prog. Polym. Sci., 31, 603, 10.1016/j.progpolymsci.2006.06.001

George, 2006, Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan—A review, J. Control. Release, 114, 1, 10.1016/j.jconrel.2006.04.017

Soares, 2016, Chitosan-based nanoparticles as drug delivery systems for doxorubicin: Optimization and modelling, Carbohydr. Polym., 147, 304, 10.1016/j.carbpol.2016.03.028

Yostawonkul, 2017, Surface modification of nanostructure lipid carrier (NLC) by oleoyl-quaternized-chitosan as a mucoadhesive nanocarrier, Colloids Surf. B Biointerfaces, 149, 301, 10.1016/j.colsurfb.2016.09.049

Yu, 2017, Preparation and characterization of mucosal adhesive and two-step drug releasing cetirizine-chitosan nanoparticle, Carbohydr. Polym., 173, 600, 10.1016/j.carbpol.2017.05.067

Abranches, 2014, Chitosan-based mucoadhesive films containing 5-aminolevulinic acid for buccal cancer treatment, J. Photochem. Photobiol. B Biol., 140, 266, 10.1016/j.jphotobiol.2014.08.005

Borsali, 2014, Mucoadhesive Films Containing Chitosan-Coated Nanoparticles: A New Strategy for Buccal Curcumin Release, J. Pharm. Sci., 103, 3764, 10.1002/jps.24142

Wen, 2016, Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel, Carbohydr. Polym., 153, 176, 10.1016/j.carbpol.2016.06.096

Santos, 2017, Manufacture and characterization of chitosan/PLGA nanoparticles nanocomposite buccal films, Carbohydr. Polym., 173, 638, 10.1016/j.carbpol.2017.06.014

Pistone, 2017, Formulation of polysaccharide-based nanoparticles for local administration into the oral cavity, Eur. J. Pharm. Biopharm., 96, 381

Giovino, 2012, Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): A potential approach for buccal delivery of macromolecules, Int. J. Pharm., 428, 143, 10.1016/j.ijpharm.2012.02.035

Kumar, 2016, Why Chitosan, From properties to perspective of mucosal drug delivery.pdf, Int. J. Biol. Macromol., 91, 615, 10.1016/j.ijbiomac.2016.05.054

Campisi, 2010, Human Buccal Mucosa as an Innovative Site of Drug Delivery, Curr. Pharm. Des., 16, 641, 10.2174/138161210790883778

Giovino, 2013, An integrated buccal delivery system combining chitosan films impregnated with peptide loaded PEG-b-PLA nanoparticles, Colloids Surf. B Biointerfaces, 112, 9, 10.1016/j.colsurfb.2013.07.019

Mazzarino, 2012, Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications, J. Colloid Interface Sci., 370, 58, 10.1016/j.jcis.2011.12.063

Suvannasara, 2013, Mucoadhesive 4-carboxybenzenesulfonamide-chitosan with antibacterial properties.pdf, Carbohydr. Polym., 94, 244, 10.1016/j.carbpol.2013.01.039

Shukla, 2012, Carbohydrate polymers: Applications and recent advances in delivering drugs to the colon, Carbohydr. Polym., 88, 399, 10.1016/j.carbpol.2011.12.021

Wang, 2016, Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis, Int. J. Pharm., 515, 176, 10.1016/j.ijpharm.2016.10.002

Cerchiara, 2015, Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods, Eur. J. Pharm. Biopharm., 92, 112, 10.1016/j.ejpb.2015.03.004

Coco, 2013, Drug delivery to inflamed colon by nanoparticles: Comparison of different strategies, Int. J. Pharm., 440, 3, 10.1016/j.ijpharm.2012.07.017

Saboktakin, 2010, Synthesis and in vitro evaluation of carboxymethyl starch chitosan nanoparticles as drug delivery system to the colon, Int. J. Biol. Macromol., 48, 381, 10.1016/j.ijbiomac.2010.10.005

Hua, 2015, Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue, Nanomedicine, 11, 1117, 10.1016/j.nano.2015.02.018

Calvo, 1999, Enhancement of nasal absorption of insulin using chitosan nanoparticles, Pharm. Res., 16, 1576, 10.1023/A:1018908705446

Ferreira, 2016, Chitosan-based nanoparticles for rosmarinic acid ocular delivery—In vitro tests, Int. J. Biol. Macromol., 84, 112, 10.1016/j.ijbiomac.2015.11.070

Frank, 2017, The use of chitosan as cationic coating or gel vehicle for polymeric nanocapsules: Increasing penetration and adhesion of imiquimod in vaginal tissue, Eur. J. Pharm. Biopharm., 114, 202, 10.1016/j.ejpb.2017.01.021

Hillaireau, 2016, Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles, Nanotoxicology, 10, 292, 10.3109/17435390.2015.1054908

Grenha, 2007, Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro, Eur. J. Pharm. Sci., 31, 73, 10.1016/j.ejps.2007.02.008

Mills, 2003, Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin A, Infect. Immun., 71, 726, 10.1128/IAI.71.2.726-732.2003

Pasetti, 2010, Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues, J. Infect. Dis., 202, 1649, 10.1086/657087

Ramirez, 2012, Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers, Clin. Immunol., 144, 98, 10.1016/j.clim.2012.05.006

Alishahi, 2011, Chitosan nanoparticle to carry vitamin C through the gastrointestinal tract and induce the non-specific immunity system of rainbow trout (Oncorhynchus mykiss), Carbohydr. Polym., 86, 142, 10.1016/j.carbpol.2011.04.028

Hembram, 2014, Advances in preparation and characterization of chitosan nanoparticles for therapeutics, Artif. Cells Nanomed. Biotechnol., 1401, 1

Henriques, 2014, The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection, Expert Rev. Anti. Infect. Ther., 12, 981, 10.1586/14787210.2014.930663

Zhao, 2011, Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles, Vaccine, 29, 8549, 10.1016/j.vaccine.2011.09.029

Zhuo, 2014, Quenching of the emission of peroxydisulfate system by ferrocene functionalized chitosan nanoparticles: A sensitive “signal off” electrochemiluminescence immunosensor, Sens. Actuators B Chem., 192, 791, 10.1016/j.snb.2013.11.032

Chen, 2007, Designing Chitosan–Dextran Sulfate Nanoparticles Using Charge Ratios, AAPS PharmSciTech, 8, E98, 10.1208/pt0804098

Leong, 1998, DNA-polycation nanospheres as non-viral gene delivery vehicles, J. Control. Release, 53, 183, 10.1016/S0168-3659(97)00252-6

Tiyaboonchai, 2003, Chitosan Nanoparticles: A Promising System for Drug Delivery, Naresuan Univ. J., 11, 51

Huang, 2005, Transfection efficiency of chitosan vectors: Effect of polymer molecular weight and degree of deacetylation, J. Control. Release, 106, 391, 10.1016/j.jconrel.2005.05.004

Bhattarai, 2006, Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery, Int. J. Nanomed., 1, 181, 10.2147/nano.2006.1.2.181

Maitra, A., Ghosh, P.K., De, T.K., and Sahoo, S.K. (1999). Process for the Preparation of Highly Monodispersed Polymeric Hydrophilic Nanoparticles. (US 5874111 A).

Wang, 2008, Adsorption of bovin serum albumin (BSA) onto the magnetic chitosan nanoparticles prepared by a microemulsion system, Bioresour. Technol., 99, 3881, 10.1016/j.biortech.2007.08.017

Niwa, 1993, Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with d,l-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method and the drug release behavior, J. Control. Release, 25, 89, 10.1016/0168-3659(93)90097-O

Vila, 2002, Design of Biodegradable Partilces for Protein Delivery, J. Control. Release, 78, 15, 10.1016/S0168-3659(01)00486-2

Zhang, 2013, Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles, Int. J. Nanomed., 8, 601

Hamed, 2017, Exploring the effect of formulation parameters on the particle size of carboxymethyl chitosan nanoparticles prepared via reverse micellar crosslinking, J. Microencapsul., 34, 270, 10.1080/02652048.2017.1321047

Malmsten, M. (2002). Surfactants and Polymers in Drug Delivery, Marcel Dekker.

Banerjee, 2002, Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles, Int. J. Pharm., 243, 93, 10.1016/S0378-5173(02)00267-3

Liu, 2007, Preparations, characterizations and applications of Chitosan-based nanoparticles, J. Ocean Univ. China, 6, 237, 10.1007/s11802-007-0237-9

Mitra, 2001, Tumour targeted delivery of encapsulated dextran–doxorubicin conjugate using chitosan nanoparticles as carrier, J. Control. Release, 74, 317, 10.1016/S0168-3659(01)00342-X

Bellich, B., D’Agostino, I., Semeraro, S., Gamini, A., and Cesàro, A. (2016). “The good, the bad and the ugly” of chitosans. Mar. Drugs, 14.

Key, J., and Park, K. (2017). Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy. Int. J. Mol. Sci., 18.

Zhang, 2016, Tumor targeting strategies for chitosan-based nanoparticles, Colloids Surf. B Biointerfaces, 148, 460, 10.1016/j.colsurfb.2016.09.020

Ahmed, 2016, Preparation, characterization and potential application of chitosan, chitosan derivatives and chitosan metal nanoparticles in pharmaceutical drug delivery, Drug Des. Devel. Ther., 10, 483, 10.2147/DDDT.S99651

Swierczewska, 2016, Polysaccharide-based nanoparticles for theranostic nanomedicine, Adv. Drug Deliv. Rev., 99, 70, 10.1016/j.addr.2015.11.015